2019 press releases
- Professor Jean-Charles Soria appointed General Director of Gustave Roussy
Press release - 16 december 2019 - Pediatric Cancers: Why Some Forms of Leukemia Only Affect Children
Press release - 29 october 2019 - Breast cancer: hormone therapy has a bigger impact than chemotherapy on women’s quality of life
Press release - 8 october 2019 - Microbiome & cancer: the ONCOBIOME consortium led by Gustave Roussy has obtained 15 m€ from Europe
Press release - 27 june 2019 - Gustave Roussy reaffirms its commitment to research integrity
Press release - 18 june 2019 - ASCO 2019 - Melanoma: The advantages of targeted dual therapy confirmed at five years
Press release - 4 June 2019 - ASCO 2019 - Urothelial cancer (bladder and urinary tract) - New evidence of the value of immunotherapy
Press release, 3 june 2019 - ASCO 2019 - Paediatric cancers: Larotrectinib, first targeted therapy for childhood solid tumours, shown to be effective
Press release, 3 june 2019 - ASCO 2019 - Artificial intelligence can predict the chances of post-treatment fatigue in breast cancer.
Press release, 1 june 2019 - ASCO 2019 - Prostate cancer: Darolutamide reduces the risk of pain and does not worsen the quality of life in patients treated for prostate cancer
Press release, 31 may 2019 - ASCO 2019 - Gustave Roussy's presentations highlights
Press kit, 30 may 2019 - XenTech Signs Strategic Collaboration Agreement with Gustave Roussy Cancer Center
Press release, 27 march 2019 - Gustave Roussy and Embleema Announce Healthcare Blockchain Initiative to Accelerate Cancer Research
Press release, 5 march 2019 - Gustave Roussy and the Institut Bergonié, partners for early phase trials and therapeutic innovation in oncology
Press release, 12 february 2019
Catégorie de la page:
